Tonix Pharmaceuticals Holding Corp (TNXP)
0.2042
+0.01
(+7.47%)
USD |
NASDAQ |
Nov 21, 16:00
0.185
-0.02
(-9.40%)
After-Hours: 07:01
Tonix Pharmaceuticals Max Drawdown (5Y): 100.00% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 100.00% |
| September 30, 2024 | 100.00% |
| August 31, 2024 | 100.00% |
| July 31, 2024 | 100.00% |
| June 30, 2024 | 100.00% |
| May 31, 2024 | 100.00% |
| April 30, 2024 | 100.00% |
| March 31, 2024 | 100.00% |
| February 29, 2024 | 100.00% |
| January 31, 2024 | 100.00% |
| December 31, 2023 | 100.00% |
| November 30, 2023 | 100.00% |
| October 31, 2023 | 100.00% |
| September 30, 2023 | 100.00% |
| August 31, 2023 | 100.00% |
| July 31, 2023 | 100.00% |
| June 30, 2023 | 100.00% |
| May 31, 2023 | 100.00% |
| April 30, 2023 | 100.00% |
| March 31, 2023 | 100.00% |
| February 28, 2023 | 100.00% |
| January 31, 2023 | 100.00% |
| December 31, 2022 | 100.00% |
| November 30, 2022 | 100.00% |
| October 31, 2022 | 100.00% |
| Date | Value |
|---|---|
| September 30, 2022 | 100.00% |
| August 31, 2022 | 100.00% |
| July 31, 2022 | 100.00% |
| June 30, 2022 | 100.00% |
| May 31, 2022 | 100.00% |
| April 30, 2022 | 100.00% |
| March 31, 2022 | 100.00% |
| February 28, 2022 | 100.00% |
| January 31, 2022 | 100.00% |
| December 31, 2021 | 100.00% |
| November 30, 2021 | 100.00% |
| October 31, 2021 | 100.00% |
| September 30, 2021 | 100.00% |
| August 31, 2021 | 100.00% |
| July 31, 2021 | 100.00% |
| June 30, 2021 | 100.00% |
| May 31, 2021 | 100.00% |
| April 30, 2021 | 100.00% |
| March 31, 2021 | 100.00% |
| February 28, 2021 | 100.00% |
| January 31, 2021 | 100.00% |
| December 31, 2020 | 100.00% |
| November 30, 2020 | 100.00% |
| October 31, 2020 | 100.00% |
| September 30, 2020 | 100.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.99%
Minimum
Nov 2019
100.00%
Maximum
Sep 2024
100.00%
Average
100.00%
Median
Feb 2020
Max Drawdown (5Y) Benchmarks
| Emergent BioSolutions Inc | 98.89% |
| Geovax Labs Inc | 100.0% |
| Abbott Laboratories | 33.88% |
| Amicus Therapeutics Inc | 74.97% |
| United Therapeutics Corp | 57.90% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -119.52 |
| Beta (5Y) | 2.065 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 155.2% |
| Historical Sharpe Ratio (5Y) | -0.5984 |
| Historical Sortino (5Y) | -1.419 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 58.00% |